Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer
Year: 2025
Type: article
Language: en
Topic: Skin and Cellular Biology Research
Authors and affiliations:
raw_author_name: Sonja Dorfer
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address: so.dorfer@crcs.at
raw_author_name: Roland Zauner
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Christina Guttmann-Gruber
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Victoria Reichl
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Michael Ablinger
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Stefanie Gruner
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Julia I. Hummel
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria
raw_author_name: Josefina Piñón Hofbauer
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Ulrich Koller
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Iris K. Gratz
raw_affiliation_strings: Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria
raw_author_name: Johann W. Bauer
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
raw_author_name: Verena Wally
raw_affiliation_strings: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria